US20020095053A1 - Preparation of 5-amino-isophthalamides - Google Patents

Preparation of 5-amino-isophthalamides Download PDF

Info

Publication number
US20020095053A1
US20020095053A1 US09/855,124 US85512401A US2002095053A1 US 20020095053 A1 US20020095053 A1 US 20020095053A1 US 85512401 A US85512401 A US 85512401A US 2002095053 A1 US2002095053 A1 US 2002095053A1
Authority
US
United States
Prior art keywords
amino
bis
isophthalamide
solution
nitroisophthalate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/855,124
Other versions
US6441235B1 (en
Inventor
Edward Parady
Karl Gelotte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/855,124 priority Critical patent/US6441235B1/en
Publication of US20020095053A1 publication Critical patent/US20020095053A1/en
Application granted granted Critical
Publication of US6441235B1 publication Critical patent/US6441235B1/en
Assigned to AMERHSAM HEALTH INC. reassignment AMERHSAM HEALTH INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: NYCOMED INC.
Assigned to GE HEALTHCARE AS reassignment GE HEALTHCARE AS CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: AMERSHAM HEALTH AS, NYCOMED IMAGING AS
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/08Preparation of carboxylic acid amides from amides by reaction at nitrogen atoms of carboxamide groups

Definitions

  • the process relates to an improved method of preparing 5-amino-N,N′-bis(R)isophthalamides, where R is 2,3-dihydroxy propyl or 1,3-dihydroxyisopropyl, which compounds are useful as intermediates in preparing iodinated diagnostic agents.
  • the invention relates to an improvement in the preparation of a compound of the formula
  • R is CH 2 CH(OH)CH 2 OH or CH(CH 2 OH) 2 , which comprises reacting a di-lower-alkyl 5-nitroisophthalate with at least two molar equivalents of a compound of the formula RNH 2 in a solvent comprising a lower-aliphatic alcohol containing a basic catalyst to obtain a solution containing 5-nitro-N,N′-bis(R)isophthalamide, and, without isolating the latter, catalytically hydrogenating said solution to obtain a solution of 5-amino-N,N′-bis(R)-isophthalamide.
  • the starting material for the process of the invention is a di-lower-alkyl 5-nitroisophthalate wherein lower-alkyl preferably has from one to four carbon atoms.
  • the conversion of the di-lower-alkyl 5-nitroisophthalate to 5-nitro-N,N′-bis(R)-isophthalamide takes place in a solvent comprising a lower-aliphatic alcohol containing a basic catalyst.
  • the lower-aliphatic alcohol solvent is preferably a lower-alkanol or lower-alkoxyalkanol of one to four carbon atoms, for example, methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methoxyethanol, 2-ethoxyethanol or 3-10 methoxypropanol.
  • the basic catalyst is a strong base preferably derived from the addition of an alkali metal to the lower-aliphatic alcohol solvent.
  • the amide formation is carried out at a temperature between about 65 and 150 C depending upon the solvent used and conveniently at approximately the boiling point of the solvent, and the reaction is complete in a few hours.
  • the amine reactant H 2 NCH 2 CH(OH)CH 2 OH, has an asymmetric carbon atom and thus exists in the racemic form and in its optically active dextro or levo forms.
  • the process of the invention can be carried out with either the racemic form or one of the optically active forms.
  • the resulting 5-amino-N,N′-bis(R)isophthalamide can be isolated in the free base form by filtering off the catalyst and removing the solvent by evaporation or distillation; or in the form of an acid-addition salt by the addition of a strong inorganic or organic acid to the product solution whereby the respective acid-addition salt separates in crystalline form from the solution.
  • acid-addition salts are the hydrochloride, hydrobromide, methanesulfonate and the like.
  • the process of the instant invention possesses several distinct advantages over the processes disclosed in the prior art.
  • the process disclosed and claimed herein can be carried out on a large scale in yield of 96.9-99.6%. This represents an improvement of 13-15% in yield over that (84%) described in British Patent 1,548,594 even assuming a quantitative yield in the catalytic hydrogenation reaction of the reference patent.
  • the instant process can be carried out in a period of five hours effective reaction time as compared with 44 hours in the process of the British patent (20 hours for the amidation and one day for the hydrogenation).
  • a 50 gallon glass-lined reactor was charged with 20.5 kg. (85.7 moles) of dimethyl 5-nitroisophthalate (m.p. 122-124° C.), 16.4 kg. of 2,3-dihydroxypropylamine, 64 liters of 2-methoxyethanol and the catalyst solution obtained above.
  • the reaction mixture was stirred at reflux (108° C.) for four hours at which point thin layer chromatography showed that no starting ester was present.
  • the resulting solution of nitro bis-amide was cooled at ambient temperature and transferred to a 50 gallon hydrogenator to which 325 g. of 10% palladium-on-carbon catalyst was then added. Hydrogenation started at 36° C.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)

Abstract

A process for preparing 5-amino-N,N′-bis(R)isophthalamides, where A is 2,3-dihydroxypropyl or 1,3-dihydroxyisopropyl, useful as intermediates in preparing iodinated diagnostic agents, which comprises reacting a di-lower-alkyl 5-nitroisophthalate with a compound of the formula RNH2 in the presence of a basic catalyst and without isolating the intermediate 5-nitro-N,N′-bis(R)isophthalamide, catalytically hydrogenating the latter.

Description

    BACKGROUND OF THE INVENTION
  • This application is a continuation of PCT/GB99/03795, filed Nov. 15, 1999 (of which the entire disclosure of the pending, prior application is hereby incorporated by reference), which itself is a continuation-in-part of application number 60/108,613, filed Nov. 16, 1998. [0001]
  • 1. Field of the Invention [0002]
  • The process relates to an improved method of preparing 5-amino-N,N′-bis(R)isophthalamides, where R is 2,3-dihydroxy propyl or 1,3-dihydroxyisopropyl, which compounds are useful as intermediates in preparing iodinated diagnostic agents. [0003]
  • 2. Description of the Prior Art [0004]
  • Nyegaard & Co. British Patent 1,548,594, published Jul. 18, 1979 describes a process for preparing 5-amino-N,N′-bis(2,3-dihydroxypropyl)isophthalamide as follows: [0005]
  • Dimethyl 5-nitro-isophthalate and 2.4 molar equivalents of 1-amino-2,3-propanediol were refluxed in methanol for twenty hours and the resulting 5-nitro-N,N′-bis(2,3-dihydroxypropyl) isophthalamide was isolated in 84% yield. The latter compound was suspended in aqueous hydrochloric acid and hydrogenated in the presence of a palladium oxide/charcoal catalyst. The resulting 5-amino-N,N′-bis(2,3-dihydroxypropyl)-isophthalamide was not isolated but the acid solution containing it was iodinated with sodium iodine dichloride to obtain 5-amino-2,4,6-triiodo-N,N′-bis(2,3-dihydroxypropyl)isophthalamide in 71% yield from the nitro compound (over-all yield of 59.5% from dimethyl 5-nitroisophthalate). Subsequent reactions are described for the preparation of 5-[N-(2,3-dihydroxy-propyl)acetamido]-2,4,6 triiodo-N,N′-bis(2,3-dihydroxypropyl)isophthalamide, useful as an X-ray contrast agent. [0006]
  • Felder et al. U.S. Pat. 4,001,323, issued Jan. 4, 1977 describes (Example 7) the reaction of 47.9 g. (0.2 mole) of dimethyl 5-nitroisophthalate and 22.8 g. (0.25 mole) of 1,3-dihydroxyisopropylamine (serinol), 5 hours at 140-150 C and the isolation of 57.2 g. of 5-nitroisophthalic acid di(1,3-dihydroxypropylamide). This represents an apparent 80% yield based on the starting ester; however it is stoichiometrically impossible to obtain this amount of product in view of the deficiency in the amount of serinol since the reaction requires two moles of amine for every mole of ester. Felder et al. further describe the hydrogenation of the nitro bis-amide in ethanol solution in the presence of palladium-carbon catalyst and iodination of the resulting 5-aminoisophthalic acid di(1,3-dihydroxy-propylamide) in 75% over-all yield. [0007]
  • SUMMARY OF THE INVENTION
  • The invention relates to an improvement in the preparation of a compound of the formula [0008]
    Figure US20020095053A1-20020718-C00001
  • where R is CH[0009] 2CH(OH)CH2OH or CH(CH2OH)2, which comprises reacting a di-lower-alkyl 5-nitroisophthalate with at least two molar equivalents of a compound of the formula RNH2 in a solvent comprising a lower-aliphatic alcohol containing a basic catalyst to obtain a solution containing 5-nitro-N,N′-bis(R)isophthalamide, and, without isolating the latter, catalytically hydrogenating said solution to obtain a solution of 5-amino-N,N′-bis(R)-isophthalamide.
  • DETAILED DESCRIPTION INCLUSIVE OF PREFERRED EMBODIMENTS
  • The starting material for the process of the invention is a di-lower-alkyl 5-nitroisophthalate wherein lower-alkyl preferably has from one to four carbon atoms. The conversion of the di-lower-alkyl 5-nitroisophthalate to 5-nitro-N,N′-bis(R)-isophthalamide takes place in a solvent comprising a lower-aliphatic alcohol containing a basic catalyst. The lower-aliphatic alcohol solvent is preferably a lower-alkanol or lower-alkoxyalkanol of one to four carbon atoms, for example, methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methoxyethanol, 2-ethoxyethanol or 3-10 methoxypropanol. The basic catalyst is a strong base preferably derived from the addition of an alkali metal to the lower-aliphatic alcohol solvent. The amide formation is carried out at a temperature between about 65 and 150 C depending upon the solvent used and conveniently at approximately the boiling point of the solvent, and the reaction is complete in a few hours. [0010]
  • The amine reactant, H[0011] 2NCH2CH(OH)CH2OH, has an asymmetric carbon atom and thus exists in the racemic form and in its optically active dextro or levo forms. The process of the invention can be carried out with either the racemic form or one of the optically active forms.
  • No isolation of the intermediate 5-nitro-N,N′-bis(R)-isophthalamide is effected, and the solution thereof is directly hydrogenated in the presence of a catalyst effective in the reduction of aromatic nitro groups to amino groups. Exemplary of such catalysts are platinum or palladium or the oxides thereof, preferably supported on carbon. The hydrogenation reaction can be initiated at room temperature or above. Hydrogenation is complete in about one hour's time. The resulting 5-amino-N,N′-bis(R)isophthalamide can be isolated in the free base form by filtering off the catalyst and removing the solvent by evaporation or distillation; or in the form of an acid-addition salt by the addition of a strong inorganic or organic acid to the product solution whereby the respective acid-addition salt separates in crystalline form from the solution. Appropriate acid-addition salts are the hydrochloride, hydrobromide, methanesulfonate and the like. [0012]
  • The process of the instant invention possesses several distinct advantages over the processes disclosed in the prior art. The process disclosed and claimed herein can be carried out on a large scale in yield of 96.9-99.6%. This represents an improvement of 13-15% in yield over that (84%) described in British Patent 1,548,594 even assuming a quantitative yield in the catalytic hydrogenation reaction of the reference patent. Furthermore, the instant process can be carried out in a period of five hours effective reaction time as compared with 44 hours in the process of the British patent (20 hours for the amidation and one day for the hydrogenation). Finally, it has been found possible to use only a 5% excess of expensive 2,3-dihydroxypropyl-amine to obtain a nearly quantitative yield of product by the instant process as compared to a 20% excess in the process of the British patent. [0013]
  • The following examples will illustrate the invention without the latter being limited thereby. [0014]
  • EXAMPLE 1
  • Dimethyl 5-nitroisophthalate (23.9 g., 0.100 mole) was slurried in 100 ml. of 2-methoxyethanol and 19.1 g. (0.210 mole) of 2,3-dihydroxypropylamine was added. The mixture was warmed until solution was complete and 0.50 g. of sodium methoxide was added. The reaction mixture was heated at reflux (108° C.) for two hours. The resulting solution was cooled to 50° C., ethanol added to provide a total volume of 300 ml., the mixture warmed to 60° C. and 1.0 g. of 10% palladium-on-carbon catalyst was added. The reaction mixture was hydrogenated on a Parr shaker for two hours after which time hydrogenation was complete. The catalyst was removed by filtration and the filtrate made strongly acid with ethanolic hydrogen chloride. The product which crystallized from solution was collected, washed with ethanol and ether and air dried to give 34.0 g. (93.7%) of the hydrochloride salt of 5-amino-N,N′-bis(2,3-dihydroxy-propyl)isophthalamide, m.p. 217-220° C. [0015]
  • EXAMPLE 2
  • To 800 ml. of 2-methoxyethanol, stirred under nitrogen, was added 1 g. of sodium metal. Stirring was continued at ambient temperature until the sodium had completely dissolved. The nitrogen was turned off and the reaction vessel charged with 191.1 g. (2.100 moles) of 2,3-dihydroxypropylamine of 97% purity and 239.0 g. (1.000 mole) of dimethyl 5-nitroisophthalate. The reaction mixture was heated at reflux (108° C.) for three hours at which time thin layer chromatography indicated only a trace of mono-amide. The hot reaction mixture was charged into a 2 liter Parr bottle and washed in with 2-methoxyethanol. About 100 ml. of additional 2-methoxyethanol was added to bring the Parr bottle to its 1200 ml. operating volume, the bottle was flushed with nitrogen, and 5.0 g. of 10% palladium-on-carbon catalyst was added. The bottle containing the mixture was placed on a shaker under hydrogen while maintaining the mixture at about 60° C. Uptake of hydrogen ceased after 2.5 hours, and the catalyst was removed by filtration and washed with 300 ml. of ethanol. To the light amber filtrate was added a large excess of ethanolic hydrogen chloride, and the product which crystallized was cooled and collected by filtration. The filter cake was washed with 400 ml. of ethanol and dried at 60° C. for 20 hours to give 357.0 g. (98.3%) of the hydrochloride salt of 5-amino-N,N′-bis(2,3-dihydroxypropyl)-isophthalamide, m.p. 216-220° C. [0016]
  • When the foregoing experiment was carried out under identical conditions but without base catalysis it required 10-12 hours to complete the amide formation. The yield was 95% and the quality of product the same. [0017]
  • An aqueous solution of 5-amino-N,N′-bis(2,3-dihydroxypropyl)isophthalamide hydrochloride was iodinated with sodium iodine dichloride to give 5-amino-2,4,6-triiodo-N,N′-bis(2,3-hydroxypropyl)isophthalamide in 73-81% crude yield (66-71% purified yield). [0018]
  • EXAMPLE 3
  • A 12 liter flask was charged with 8 liters of 2-methoxyethanol and the system blanketed with nitrogen. Sodium metal (86 g.) was added in small pieces over 45 minutes, allowing the temperature to rise from 25° C. to 55° C. The mixture was stirred until the sodium had completely dissolved to form a catalyst solution for the following reaction. [0019]
  • A 50 gallon glass-lined reactor was charged with 20.5 kg. (85.7 moles) of dimethyl 5-nitroisophthalate (m.p. 122-124° C.), 16.4 kg. of 2,3-dihydroxypropylamine, 64 liters of 2-methoxyethanol and the catalyst solution obtained above. The reaction mixture was stirred at reflux (108° C.) for four hours at which point thin layer chromatography showed that no starting ester was present. The resulting solution of nitro bis-amide was cooled at ambient temperature and transferred to a 50 gallon hydrogenator to which 325 g. of 10% palladium-on-carbon catalyst was then added. Hydrogenation started at 36° C. and was complete in about one hour with an exothermic effect, the temperature reaching a maximum of 106° C. The reaction mixture was stirred for an additional hour, the catalyst filtered off, and the unit and filter washed with an additional 32 liters of 2-methoxyethanol. The resulting solution was cooled to 25° C. and ethanolic hydrogen chloride (5 kg. of anhydrous hydrogen chloride in 24 liters of ethanol) was added. The system was cooled to 0° C. with stirring and the crystalline material which separated was collected by filtration, washed with 64 liters of cold ethanol and dried in vacuo at 60° C. for 24 hours to afford 30.2 kg. (96.9%) of the hydrochloride salt of 5-amino-N,N′-bis-(2,3-dihydroxypropyl) isophthalamide, m.p. 211-214° C. A duplicate run gave a 99.6% yield of product. Thin layer chromatographic analysis indicated that the product was over 99% pure containing small traces of inorganic salts which could readily be removed by slurry in methanol. [0020]
  • By replacement of the 2,3-dihydroxypropylamine in the foregoing preparation by an equal amount of 1,3-dihydroxy-2-propylamine and following exactly the same procedure it is contemplated that 5-amino-N,N′-bis(1,3-dihydroxy-2-propyl)isophthalamide or an acid-addition salt thereof can be prepared in yield comparable to that realized for the isomeric compound. [0021]

Claims (7)

What is claimed is:
1. The process for preparing a compound of the formula
Figure US20020095053A1-20020718-C00002
where R is CH2CH(OH)CH2OH or CH(CH2OH)2, which comprises reacting a di-lower-alkyl 5-nitroisophthalate with at least two molar equivalents of a compound of the formula RNH2 in a solvent comprising a lower-aliphatic alcohol containing a basic catalyst to obtain a solution containing 5-nitro-N,N′-bis(R)isophthalamide, and, without isolating the latter, catalytically hydrogenating said solution to obtain a solution of 5-amino-N,N′-bis(R)isophthalamide.
2. The process according to claim 1 in which the 5-amino-N,N′-bis(R)isophthalamide is subsequently isolated either in the form of the free base or an acid-addition salt.
3. The process according to claim 1 wherein the base catalysis is provided by the addition of a solution derived from dissolving metallic sodium in a lower-aliphatic alcohol.
4. The process according to claim 1 wherein the lower-aliphatic alcohol is 2-methoxyethanol.
5. The process according to claim 1 wherein R is CH2CH(OH)CH2OH and the di-lower-alkyl 5-nitroisophthalate is dimethyl 5-nitroisophthalate.
6. The process for preparing 5-amino-N,N′-bis(2,3-dihydroxypropyl)isophthalamide which comprises heating at reflux temperature a solution of dimethyl 5-nitroisophthalate and about 2.1 molar equivalents of 3-amino-1,2-propanediol in 2-methoxyethanol containing a catalytic amount of dissolved sodium until essentially all of the dimethyl 5-nitroisophthalate has been consumed, and hydrogenating said mixture in the presence of a palladium-on-carbon catalyst until reduction of the nitro group to an amino group is essentially complete.
7. The process according to claim 6 in which the 5-amino-N,N′-bis(2,3-dihydroxypropyl)isophthalamide is isolated in the form of its hydrochloride salt by adding hydrogen chloride as a gas or a solution in a lower-alkanol.
US09/855,124 1998-11-16 2001-05-14 Preparation of 5-amino-isophthalamides Expired - Lifetime US6441235B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/855,124 US6441235B1 (en) 1998-11-16 2001-05-14 Preparation of 5-amino-isophthalamides

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US10861398P 1998-11-16 1998-11-16
GB9825095.4 1998-11-16
GB9825095 1998-11-16
GBGB9825095.4A GB9825095D0 (en) 1998-11-16 1998-11-16 Chemical process
PCT/GB1999/003795 WO2000029372A1 (en) 1998-11-16 1999-11-15 Preparation of 5-amino-isophthalamides
US09/855,124 US6441235B1 (en) 1998-11-16 2001-05-14 Preparation of 5-amino-isophthalamides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1999/003795 Continuation WO2000029372A1 (en) 1998-11-16 1999-11-15 Preparation of 5-amino-isophthalamides

Publications (2)

Publication Number Publication Date
US20020095053A1 true US20020095053A1 (en) 2002-07-18
US6441235B1 US6441235B1 (en) 2002-08-27

Family

ID=10842530

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/855,124 Expired - Lifetime US6441235B1 (en) 1998-11-16 2001-05-14 Preparation of 5-amino-isophthalamides

Country Status (10)

Country Link
US (1) US6441235B1 (en)
EP (1) EP1131280B1 (en)
JP (1) JP4721518B2 (en)
AT (1) ATE273271T1 (en)
AU (1) AU1066600A (en)
DE (1) DE69919382T2 (en)
ES (1) ES2226455T3 (en)
GB (1) GB9825095D0 (en)
NO (1) NO328678B1 (en)
WO (1) WO2000029372A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7863484B1 (en) 2009-07-21 2011-01-04 Ge Healthcare As Method for reducing aminoisophthalic acid bisamide related impurities in preparation of non-ionic X-ray contrast agents

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1319670B1 (en) * 2000-12-01 2003-10-23 Bracco Spa PROCESS FOR THE PREPARATION OF 5-AMINO-N, N'-BIS (2-HYDROXY-1- (HYDROXYMETHYL) ETHYL)) - 1,3-BENZENDICARBOSSAMIDE (I) AND 5-AMINO-N, N'-
EP2277846A1 (en) 2009-07-21 2011-01-26 GE Healthcare AS Obtaining free iodine in preparation of aqueous iodine chloride by adding potassium iodide
US9006486B2 (en) 2013-01-15 2015-04-14 Liebel-Flarsheim Company Llc Synthesis of N1,N3-bis(2,3-dihydroxypropyl)-5-nitroisophthalamide
ES2674279T3 (en) 2013-11-05 2018-06-28 Bracco Imaging S.P.A. Process for the preparation of Iopamidol
CN108341750B (en) * 2017-01-21 2020-10-23 浙江海洲制药有限公司 Synthetic method of impurities generated in preparation of iodinated contrast medium intermediate
GB202009917D0 (en) 2020-06-29 2020-08-12 Ge Healthcare As Process for the preparation of iopamidol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608189A5 (en) * 1974-12-13 1978-12-29 Savac Ag
GB1548594A (en) * 1976-06-11 1979-07-18 Nyegaard & Co As Triiodoisophthalic acid amides
US4256729A (en) * 1979-03-23 1981-03-17 Mallinckrodt, Inc. N,N'-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-keto-L-gulonamido)isophthalamide and radiological compositions containing same
EP1186305A1 (en) * 2000-09-07 2002-03-13 Schering Aktiengesellschaft New brominated compounds as contrast media for X-ray mammography

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7863484B1 (en) 2009-07-21 2011-01-04 Ge Healthcare As Method for reducing aminoisophthalic acid bisamide related impurities in preparation of non-ionic X-ray contrast agents
CN101955444A (en) * 2009-07-21 2011-01-26 通用电气医疗集团股份有限公司 Reduce the method for impurity relevant in the preparation of nonionic x-ray contrast agent with amino m-phthalic acid bisamide
US20110021814A1 (en) * 2009-07-21 2011-01-27 Ge Healthcare As Method for reducing aminoisophthalic acid bisamide related impurities in preparation of non-ionic x-ray contrast agents
EP2289870A1 (en) * 2009-07-21 2011-03-02 GE Healthcare AS Method for purifying 5-amino-N,N'-bis(2,3-dihydroxypropyl)-isophthalamide, an intermediate in the preparation of non-ionic X-ray contrast agents

Also Published As

Publication number Publication date
JP4721518B2 (en) 2011-07-13
NO20012325L (en) 2001-05-11
NO20012325D0 (en) 2001-05-11
EP1131280B1 (en) 2004-08-11
WO2000029372A1 (en) 2000-05-25
JP2002529530A (en) 2002-09-10
ES2226455T3 (en) 2005-03-16
NO328678B1 (en) 2010-04-26
ATE273271T1 (en) 2004-08-15
DE69919382T2 (en) 2005-10-06
US6441235B1 (en) 2002-08-27
EP1131280A1 (en) 2001-09-12
GB9825095D0 (en) 1999-01-13
AU1066600A (en) 2000-06-05
DE69919382D1 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
TWI401237B (en) Preparation of 3-[(1r, 2r)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol monohydrochloride
JP4148952B2 (en) (1S) -4,5-dimethoxy-1- (methylaminomethyl) benzocyclobutane and a novel method for the synthesis of its addition salts and its application to the synthesis of ivabradine and its addition salts with pharmaceutically acceptable acids
JP5277130B2 (en) Novel synthesis method of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds and application to the synthesis of ivabradine and its addition salts with pharmaceutically acceptable acids
US6441235B1 (en) Preparation of 5-amino-isophthalamides
KR19990013522A (en) Process for preparing substituted perhydroisoindole
AU2002226359B8 (en) A process for the preparation of N,N'-substituted 5-amino-1,3-benzenedicarboxamides
JP4326147B2 (en) Process for producing optically active amino alcohols
AU2002226359A1 (en) A process for the preparation of N,N'-substituted 5-amino-1,3-benzenedicarboxamides
JPH02740A (en) Preparation of halogenated aromatic primary amine
JPH05239005A (en) N-(2-aminoethyl)benzamides and their new intermediate
CA2349826C (en) Process for the synthesis of 1-(aminomethyl)cyclohexyl-acetic acid
WO2000039071A1 (en) Process for producing l-erythro-(1r,2s)-2-amino-1-phenylpropan-1-ol
JPH1045692A (en) Production of cyclohexylamino acids
JP3544701B2 (en) Method for producing N, N-disubstituted benzylamine
JPH08311001A (en) Production of optically active amine
JP4314602B2 (en) Process for producing optically active 3-hydroxypyrrolidine derivative
JPS629587B2 (en)
JP3242328B2 (en) Method for producing phenylacetic acid derivative
JP2004504261A (en) Production of hydrogenated primary amines
US5571928A (en) 4-amino-3-hydroxy-phthalimidine, and a process for the preparation thereof
JP2009519994A (en) Method for producing aminoalkanoic acid amide
JP4072651B2 (en) Process for producing 4-aminoresorcinol or a salt thereof
CA1241018A (en) Synthesis of 9-carbamoyl 9-(3-aminopropyl)fluorenes
JPH07157453A (en) Production of n-(3-amono-propyl)amine
JP2002193940A (en) PRODUCTION METHOD OF 6-AMINOMETHYL-6,11-DIHYDRO-5H- DIBENZ[b,e]AZEPINE

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: AMERHSAM HEALTH INC., NEW JERSEY

Free format text: CHANGE OF NAME;ASSIGNOR:NYCOMED INC.;REEL/FRAME:014119/0633

Effective date: 20010926

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: GE HEALTHCARE AS,NORWAY

Free format text: CHANGE OF NAME;ASSIGNORS:AMERSHAM HEALTH AS;NYCOMED IMAGING AS;REEL/FRAME:018039/0537

Effective date: 20060329

Owner name: GE HEALTHCARE AS, NORWAY

Free format text: CHANGE OF NAME;ASSIGNORS:AMERSHAM HEALTH AS;NYCOMED IMAGING AS;REEL/FRAME:018039/0537

Effective date: 20060329

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12